Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2

Atsushi Hijikata, Clara Shionyu‐Mitsuyama, Setsu Nakae, Masafumi Shionyu, Motonori Ota, Shigehiko Kanaya, Takatsugu Hirokawa, Shogo Nakajima, Koichi Watashi, Tsuyoshi Shirai

Open source

DOI: 10.1002/2211-5463.13337
Published: 2021-12-09
Container: FEBS Open Bio
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/2211-5463.13337,
  title = {Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2},
  author = {Atsushi Hijikata and Clara Shionyu‐Mitsuyama and Setsu Nakae and Masafumi Shionyu and Motonori Ota and Shigehiko Kanaya and Takatsugu Hirokawa and Shogo Nakajima and Koichi Watashi and Tsuyoshi Shirai},
  year = {2021},
  journal = {FEBS Open Bio},
  doi = {10.1002/2211-5463.13337},
  url = {https://doi.org/10.1002/2211-5463.13337}
}

RIS

TY  - JOUR
TI  - Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
AU  - Atsushi Hijikata
AU  - Clara Shionyu‐Mitsuyama
AU  - Setsu Nakae
AU  - Masafumi Shionyu
AU  - Motonori Ota
AU  - Shigehiko Kanaya
AU  - Takatsugu Hirokawa
AU  - Shogo Nakajima
AU  - Koichi Watashi
AU  - Tsuyoshi Shirai
PY  - 2021
JO  - FEBS Open Bio
DO  - 10.1002/2211-5463.13337
UR  - https://doi.org/10.1002/2211-5463.13337
ER  -

APA

Hijikata, A., Shionyu‐Mitsuyama, C., Nakae, S., Shionyu, M., Ota, M., Kanaya, S., Hirokawa, T., Nakajima, S., Watashi, K., & Shirai, T. (2021). Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2. FEBS Open Bio. https://doi.org/10.1002/2211-5463.13337

Source records

crossref · retrieved 2026-09-26T00:59:40.315Z